Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 167
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01818687 | Safety and Tolerability Study of MCI-196 | ||
| NCT03188692 | Safety and Efficacy of BK1310 Intramuscular Injection in Healthy Infants | ||
| NCT03439137 | Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan | ||
| NCT01861522 | The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis | ||
| NCT01889277 | Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic Nephropathy | ||
| NCT03664544 | PK Study in Subjects With Severe Hepatic Impairment | ||
| NCT02307643 | Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients | ||
| NCT01625182 | Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients. | ||
| NCT00412867 | Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke （Japan Alteplase Clinical Trial Ⅱ：J-ACT Ⅱ） | ||
| NCT06196905 | An Exploratory Study of MT-2990 in Patients With AAV | ||
| NCT01814904 | Dose-finding Study of MCI-196 | ||
| NCT00307749 | Safety and Efficacy of MCC-257 in the Treatment of Diabetic Polyneuropathy | ||
| NCT03172598 | Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy | ||
| NCT02429102 | A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-8554 in Healthy Subjects | ||
| NCT01680159 | A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis | ||
| NCT02517320 | Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy | ||
| NCT02310048 | Comparative Oral Bioavailability Study of MT-1303 | ||
| NCT02148185 | Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Study of MT-1303 in Subjects With Crohn's Disease | ||
| NCT00772382 | Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia | ||
| NCT00129805 | Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS) | ||
| NCT01900054 | A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis | ||
| NCT03156738 | A Clinical Study to Investigate How Safe and Tolerable the Study Drug MT-2990 is and How MT-2990 is Taken up by the Body in Healthy Volunteers | ||
| NCT00059644 | Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease | ||
| NCT00508924 | Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI) | ||
| NCT01022112 | An Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 Diabetes | ||
| NCT01585155 | Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis | ||
| NCT01625000 | Safety and Efficacy of MP-214 in Patients With Schizophrenia | ||
| NCT03507738 | Safety and Immunogenicity of MT-5625 in Healthy Adults, Toddlers and Infants | ||
| NCT01878474 | Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 With Single, Escalating Doses in Healthy Subjects | ||
| NCT01512849 | A Study to Evaluate the PK/PD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment | ||
| NCT00456326 | Heparin-Induced Thrombocytopenia Registry | ||
| NCT04029090 | A Study to Evaluate the Effect of MCI-186 at Therapeutic and Supra-Therapeutic Doses on the QT Interval(QT)/Corrected QT Interval(QTc) Interval in Healthy Subjects | ||
| NCT04493281 | Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects | ||
| NCT00451295 | A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia | ||
| NCT02389790 | Extension Study of MT-1303 in Subjects With Crohn's Disease | ||
| NCT03891758 | Confirmatory Study of BK1310 in Healthy Infants | ||
| NCT02675309 | A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects | ||
| NCT01143337 | Efficacy and Safety Study of MP-435 in Combination With Methotrexate (MTX) in Patients With Rheumatoid Arthritis | ||
| NCT02676401 | An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy | ||
| NCT01879020 | Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 After Multiple Doses in Healthy Subjects | ||
| NCT00628212 | Efficacy and Safety Study of MP-513 in Patients With Type 2 Diabetes | ||
| NCT00424463 | Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (ALS) | ||
| NCT02327182 | Safety Study of MT-4666 in Subjects With Alzheimer's Disease | ||
| NCT00416520 | A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia | ||
| NCT01072331 | Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes Mellitus | ||
| NCT01756716 | A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR | ||
| NCT00246922 | Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07) | ||
| NCT01492686 | Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis | ||
| NCT00781274 | Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Chronic Hepatitis C Who Have Not Achieved an Undetectable HCV RNA Level With Previous Interferon Based Therapy | ||
| NCT00670449 | An Extension Study of the Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing Multiple Sclerosis |
